Choking access to drugs

Drug prices are likely to increase as rich countries and their pharma companies squeeze Indian generics out of the market. How can India’s …

Moneymakers

Patent hypocrisies of US

American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards

Any cheers for Doha pact?

The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …

Suffering SARS

Is the crisis spawned by this new viral infection a failure of global health governance?

Caught off guard

SARS unravelled

The pathogen's path

In Short - News

Hidden industry hand

Attempts are on to derail UN initiative to declare noncommunicable diseases a global priority

Annual numbers of excess deaths in the US relative to other developed countries are growing at an alarming rate

Obesity, cardiovascular diseases, drug overdoses and homicides mainly to blame

Lack of access, erratic use magnify antimicrobial infections in Africa

Only five of the 15 antibiotic-resistant bacteria listed by the WHO as priority pathogens are being tested in the continent

Ethics vs economics: the cost of outsourcing clinical trials to developing countries

On Human Experiments – As demand grows for newer and better drugs for an expanding range of conditions, so too does the need for clinical …

News 360° - Briefs

Get your own vaccine

Fruitful deliberations

Two global meetings chart a course for weeding out biopiracy

Superbug prompts antibiotics policy

Standard treatment guidelines will determine drug prescription

THE MONEY MAKERS

US food authorities pander to drug companies

News 360°- Briefs

News 360° - Briefs

Big pharma’s dirty tricks

Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India

Disclosure-shy industry

Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues

Victims of vaccination

Vaccine trials in a Madhya Pradesh government hospital are making children sick. Culprit: harmful chemicals in high amounts